Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.018 seconds
Volkow, N.D.; Fowler, J.S.; SUNY, Stony Brook, Stony Brook, NY
Brookhaven National Lab., Upton, NY (United States). Funding organisation: USDOE, Washington, DC (United States)1995
Brookhaven National Lab., Upton, NY (United States). Funding organisation: USDOE, Washington, DC (United States)1995
AbstractAbstract
[en] These studies document dopaminergic abnormalities in cocaine abusers. They also suggest a regulatory role of Dopamine (DA) in frontal metabolism. The correlation of striatal D2 receptor availability with metabolism was strongest for orbital frontal cortex (OFC) cingulate and prefrontal cortices. In cocaine abusers tested during early withdrawal (<1 week) the OFC was found to be hypermetabolic and metabolism in OFC and prefrontal cortices were found to be significantly associated with cocaine craving . Thus, we postulate that repeated and intermittent DA stimulation, as seen during a cocaine binge, activates the prefrontal and OFC cortices increasing the drive to compulsively self-administer cocaine. During cocaine discontinuation and protracted withdrawal and with decreased DA stimulation, these frontal cortical regions become hyponietabolic. Dopaminergic stimulation by a DA-enhancing drug and/or environmental conditioning will reactivate these frontal regions resetting the compulsion to self-administer cocaine and the inability to terminate this behavior. The pharmacokionetic studies with [11C]cocaine are consistent with behavioral and pharmacological studies in animals as well as in vitro studies which have revealed that while the mechanisms for cocaine's reinforcing properties are complex, they partly involve the brain's dopamine system and also highlight the importance of cocaine's pharmacokinetic on its unique reinforcing properties
Primary Subject
Secondary Subject
Source
1995; 14 p; CONTRACT AC02-76CH00016; Also available from OSTI as DE95013846; NTIS; US Govt. Printing Office Dep
Record Type
Report
Report Number
Country of publication
ALDEHYDES, ALKALOIDS, AMINES, ANESTHETICS, ANTIDEPRESSANTS, AROMATICS, AUTONOMIC NERVOUS SYSTEM AGENTS, BETA DECAY RADIOISOTOPES, BETA-PLUS DECAY RADIOISOTOPES, BODY, CARBOHYDRATES, CARBON ISOTOPES, CARDIOTONICS, CARDIOVASCULAR AGENTS, CENTRAL NERVOUS SYSTEM, CENTRAL NERVOUS SYSTEM AGENTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS, CEREBRUM, COMPUTERIZED TOMOGRAPHY, DISEASES, DRUGS, EMISSION COMPUTED TOMOGRAPHY, EVEN-ODD NUCLEI, FLUORINE ISOTOPES, HEXOSES, HOURS LIVING RADIOISOTOPES, HYDROXY COMPOUNDS, ISOMERIC TRANSITION ISOTOPES, ISOTOPE APPLICATIONS, ISOTOPES, KINETICS, LIGHT NUCLEI, MINUTES LIVING RADIOISOTOPES, MONOSACCHARIDES, NERVOUS SYSTEM, NEUROREGULATORS, NUCLEI, ODD-ODD NUCLEI, ORGANIC COMPOUNDS, ORGANS, PHENOLS, POLYPHENOLS, PSYCHOTROPIC DRUGS, RADIOISOTOPES, REACTION KINETICS, SACCHARIDES, SYMPATHOMIMETICS, TOMOGRAPHY
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue